: +88% Capitalized on a global shortage and surge in demand for memory chips used in smartphones and data centers.
: Outside the S&P 500, some smaller biotech firms like Madrigal Pharmaceuticals posted astronomical gains exceeding 500% .
: +103% Gains were driven by breakthroughs in cystic fibrosis treatments and robust revenue growth. best 10 stocks to buy 2017
: +87% The nation's largest homebuilder profited from high demand, low unemployment, and a shortage of affordable housing.
: +81% Transitioned from a gaming chipmaker to an AI powerhouse, with its data center business experiencing rapid expansion. : +88% Capitalized on a global shortage and
: +132% A utility play that successfully executed a massive "transformation plan" involving debt reduction and asset sales.
: +87% Rode the wave of the digital payments boom and significant customer growth following its 2015 split from eBay. : +87% The nation's largest homebuilder profited from
: Biotech and pharmaceutical companies like Vertex saw triple-digit returns due to clinical trial breakthroughs.